| Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus. | sarcoma, |
| Characterization of a human colon/lung carcinoma oncogene. | colorectal,lung, |
| A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. | adrenocortical, |
| Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. | lymphoma, |
| Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. | lung, |
| [A comparative study of the expression of ras oncogenic protein P21 and oncofetal protein AFP, CEA in human hepatocellular carcinoma (HCC)]. | liver, |
| Comparative immunohistochemical study of ras-p21 oncoprotein in adenomatous hyperplasia and adenocarcinoma of the prostate gland. | prostate, |
| Erratum and apology re: Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. | lung, |
| Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. | lung, |
| Immunohistochemical detection of ras P21 oncoprotein in human skin lesions. | skin, |
| Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. | colorectal, |
| [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma]. | pancreatic, |
| [Oncogenic activation of p21(ras) and pp60(c-src) in human colonic Caco-2 cells decreases insulin receptor function and expression through protein kinase C-dependent and independent pathways]. | colorectal, |
| [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. | pancreatic,neoplasm, |
| Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. | lung, |
| G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. | lung, |
| [Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon]. | colorectal, |
| Detection of high incidence of H-RAS oncogene point mutations in acute myelogenous leukemia. | leukemia, |
| [Quantitative study of oncogene p21ras expression in premalignant lesion and carcinoma of the stomach]. | gastric, |
| Ki-ras oncogene activation in transplantable rat thyroid carcinoma induced by N-bis(2-hydroxypropyl)nitrosamine. | thyroid, |